Back to ALNY
T. Rowe Price Investment Management, Inc. → ALNY
T. Rowe Price Investment Management, Inc. ALNY Position History
Alnylam Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$2.5B
Q3 2026
Peak value
$2.5B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $457.8M |
| Q4 2025 | $697.3M |
| Q1 2026 | $1.7B |
| Q2 2026 | $1.7B |
| Q3 2026 | $2.5B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.5B | 10.01M | — | — |
| Q2 2026 | $1.7B | 5.64M | — | — |
| Q1 2026 | $1.7B | 5.19M | — | — |
| Q4 2025 | $697.3M | 1.75M | — | — |
| Q4 2025 | $457.8M | 1.15M | — | — |
Other funds holding ALNY
$5.8B
$5.7B
$4.9B
$4.8B
$4.2B
$3.4B